InflaRx N.V. - Ordinary Shares, nominal value (euro)0.12 per share (IFRX)
CUSIP: N44821101
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Ordinary Shares, nominal value (euro)0.12 per share
- Shares outstanding
- 147,959,184
- Total 13F shares
- 5,017,755
- Share change
- -271,100
- Total reported value
- $19,163,764
- Price per share
- $3.82
- Number of holders
- 22
- Value change
- -$1,154,104
- Number of buys
- 13
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP N44821101?
CUSIP N44821101 identifies IFRX - InflaRx N.V. - Ordinary Shares, nominal value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N44821101:
Top shareholders of IFRX - InflaRx N.V. - Ordinary Shares, nominal value (euro)0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,778,415
|
$7,043,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
902,381
|
$3,574,000 | — | 31 Dec 2019 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.34%
|
500,000
|
$1,980,000 | — | 31 Dec 2019 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.24%
|
359,128
|
$1,422,000 | — | 31 Dec 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.23%
|
334,618
|
$1,325,087 | — | 31 Dec 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.22%
|
330,000
|
$1,307,000 | — | 31 Dec 2019 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.15%
|
220,000
|
$869,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
165,902
|
$657,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
120,070
|
$475,000 | — | 31 Dec 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
110,506
|
$438,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
105,802
|
$419,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
87,779
|
$347,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
62,475
|
$247,000 | — | 31 Dec 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
60,056
|
$238,000 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
50,000
|
$198,000 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.03%
|
45,078
|
$179,000 | — | 31 Dec 2019 | |
| Leap Investments LP |
13F
|
Company |
0.02%
|
34,918
|
$138,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
11,752
|
$47,000 | — | 31 Dec 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
10,175
|
$41,000 | — | 31 Dec 2019 |
Institutional Holders of InflaRx N.V. - Ordinary Shares, nominal value (euro)0.12 per share (IFRX) as of Q1 2020
As of 31 Mar 2020,
InflaRx N.V. - Ordinary Shares, nominal value (euro)0.12 per share (IFRX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,017,755 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, FNY Investment Advisers, LLC, Ikarian Capital, LLC, Eversept Partners, LP, GOLDMAN SACHS GROUP INC, Birchview Capital, LP, Point72 Asset Management, L.P., and MORGAN STANLEY.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
19
Q1 2020 holders
22
Holder diff
3
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.